Related Experiment Video
Updated: May 18, 2026

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Glutathionylation state of uncoupling protein-2 and the control of glucose-stimulated insulin secretion
Ryan J Mailloux1, Accalia Fu, Christine Robson-Doucette
1Department of Biochemistry, Microbiology, and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5.
Abstract:
The role of reactive oxygen species (ROS) in glucose-stimulated insulin release remains controversial because ROS have been shown to both amplify and impede insulin release. In regard to preventing insulin release, ROS activates uncoupling protein-2 (UCP2), a mitochondrial inner membrane protein that negatively regulates glucose-stimulated insulin secretion (GSIS) by uncoupling oxidative phosphorylation. With our recent discovery that the UCP2-mediated proton leak is modulated by reversible glutathionylation, a process responsive to small changes in ROS levels, we resolved to determine whether glutathionylation is required for UCP2 regulation of GSIS. Using Min6 cells and pancreatic islets, we demonstrate that induction of glutathionylation not only deactivates UCP2-mediated proton leak but also enhances GSIS. Conversely, an increase in mitochondrial matrix ROS was found to deglutathionylate and activate UCP2 leak and impede GSIS. Glucose metabolism also decreased the total amount of cellular glutathionylated proteins and increased the cellular glutathione redox ratio (GSH/GSSG). Intriguingly, the provision of extracellular ROS (H(2)O(2), 10 μM) amplified GSIS and also activated UCP2. Collectively, our findings indicate that the glutathionylation status of UCP2 contributes to the regulation of GSIS, and different cellular sites and inducers of ROS can have opposing effects on GSIS, perhaps explaining some of the controversy surrounding the role of ROS in GSIS.
Insights
Reactive oxygen species (ROS) impact insulin release differently based on location. Glutathionylation of uncoupling protein-2 (UCP2) enhances insulin secretion, while mitochondrial ROS impede it.
Area of Science:
- * Cellular biology
- * Metabolic research
- * Endocrinology
Background:
- * Reactive oxygen species (ROS) have paradoxical effects on glucose-stimulated insulin secretion (GSIS).
- * Uncoupling protein-2 (UCP2) is a mitochondrial protein that inhibits GSIS by uncoupling oxidative phosphorylation.
- * UCP2 activity is modulated by glutathionylation, a reversible modification influenced by ROS levels.
Purpose of the Study:
- * To investigate if glutathionylation is essential for UCP2's regulation of GSIS.
- * To explore the opposing effects of intracellular and extracellular ROS on GSIS.
- * To clarify the role of ROS in the controversy surrounding insulin release regulation.
Main Methods:
- * Experiments conducted using Min6 cells and pancreatic islets.
- * Analysis of UCP2-mediated proton leak and its modulation by glutathionylation.
- * Measurement of GSIS under varying ROS conditions and assessment of protein glutathionylation status and glutathione redox ratio (GSH/GSSG).
Main Results:
- * Induction of glutathionylation deactivated UCP2 proton leak and enhanced GSIS.
- * Increased mitochondrial ROS led to UCP2 activation and impaired GSIS.
- * Extracellular ROS (H2O2) amplified GSIS and activated UCP2.
Conclusions:
- * The glutathionylation status of UCP2 is a key factor in regulating GSIS.
- * ROS from different cellular compartments can exert opposing influences on GSIS.
- * These findings help explain the conflicting roles of ROS in insulin secretion.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin Secretory Vesicles
Insulin: The Receptor and Signaling Pathways
Type II Diabetes II: Pathophysiology

